// App-Quantinova.ai

: When and How to Screen for Glucose Dysregulation (GD) in patients with β-Thalassemia Major (β-TM): A retrospective study by The International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescent Medicine (ICET-A)

Researchers

Presenter

  • Vincenzo De Sanctis

Principal Investigators

  • Ashraf Soliman

  • Shahina Daar

  • Ploutarchos Tzoulis

  • Mehran Karimi

  • Salvatore Di Maio

  • Christos Kattamis

Medical Centers

  • Quisisana Hospital, Ferrara, Italy

  • Hamad Medical Center, Pediatrics, Doha, Qatar

  • College of Medicine, Sultan Qaboos University, Muscat, Oman

  • Department of Diabetes and Endocrinology, Whittington Hospital, University College London, London, United Kingdom

  • QH, United Kingdom

  • Hematology Research Center,, Shiraz University of Medical Sciences, Shiraz, Iran

  • Children’s Hospital ‘Santobono-Pausilipon’, Pediatrics, Naples, Italy

  • National Kapodistrian University of Athens 11527, Greece, Pediatrics, Athens, Greece

Locations

  • Italy

  • Qatar

  • Oman

  • United Kingdom

  • Iran

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Ophthalmology (OP)

  • Genetic Disorder

Disease

  • Beta-thalassemia

Biomarkers

  • N/A

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved